CORAL GABLES, FL / ACCESSWIRE / November 4, 2015 / Private sector employment reports showed that nearly 200,000 jobs were created last month; his is according to ADP. Furthermore the services index also rose in September, more than expected by the street and marked the highest level in the last 3 months. Despite US markets being mixed on this new data, several stocks have seen an increased in trading volumes and news flow during the first week of November. FBEC Worldwide, Inc. (OTCQB: FBEC), Aeterna Zentaris (NASDAQ: AEZS), and BioScrip, Inc. (NASDAQ: BIOS) have seen an influx of news and trading activity since Monday.
FBEC Worldwide, Inc. announced on Tuesday that the Company will resume retail sales of its flagship product, WolfShot Hemp Energy via the virtual stores on Alibaba.com, Ebay.com, and on the company's website, www.WolfEnergyShot.com. The company also stated that it plans to announce addition sales destinations in the future. Since hitting lows of $0.011 in September, shares of FBEC have rebounded by more than 290% during the weeks leading up to the announcement. Company CEO Jason Spatafora stated that, "WolfShot(TM) is the only hemp infused energy drink on the market that I know of using 100% real hemp juice. Competing products use either hemp seed oil or hemp powder. Hemp juice is derived from the actual hemp plant itself and, therefore, contains phytonutrients that oil and powder do not. When looking at the health benefits of hemp juice versus hemp oil or powder, a comparable analogy would be a shot of wheatgrass compared to a slice of wheat bread."
Aeterna Zentaris, Inc. announced on Monday that it would be agreeing to exercise all remaining Series B warrants as well as hosting a quarterly conference call this Friday, November 6th. Since making the announcement shares of AEZS have reacted favorably. Monday the stock opened at a price of $0.0455 and has since hit a high on Wednesday morning of $0.0725. The total jump from open to high was 59.34%.
Finally, BioScrip reported its third quarter financials Wednesday morning. Results showed that the company produced an adjusted EBITDA of $6.2million while revenue from operations generated just over $247.2m. That represented an increase of roughly 7% above the period during the year prior. Rick Smith, CEO of BioScrip stated, "We are pleased with the early progress we have made on our Financial Improvement Plan, and expect to see additional benefits through the remainder of the year."
The stock has traded more than 2.7 million shares and has seen an intra-day price increase of more than 30% from an opening price of $2.22 to a high of $2.98 prior to the lunch hour.
ABOUT US:
DailyStockReporter.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals DailyStockReporter.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. You can subscribe to the DailyStockReporter.com newsletter and start receiving daily alerts. To subscribe by phone and receive messages directly to a mobile phone, text the phrase "StockAlerts" to 63566.
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.
EGM FIRM INC, which owns DailyStockReporter.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release.
EGM FIRM INC, which owns DailyStockReporter.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice.
EGM FIRM INC, which owns DailyStockReporter.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.
CONTACT:
Company: DailyStockReporter.com
Contact Email: news@dailystockreporter.com
SOURCE: DailyStockReporter.com
